Latest Rakesh Jain Stories
A new report published in the Proceedings of the National Academy of Science (PNAS) Early Edition details a study funded in part by the National Foundation for Cancer Research, which indicates
Advanced imaging techniques may be able to distinguish which patients' tumors will respond to treatment with anti-angiogenic drugs and which will not.
Use of existing, well-established hypertension drugs could improve the outcome of cancer chemotherapy by opening up collapsed blood vessels in solid tumors.
A new way of analyzing data acquired in MR imaging appears to be able to identify whether or not tumors are responding to anti-angiogenesis therapy, information that can help physicians determine the most appropriate treatments and discontinue ones that are ineffective.
It's a high-pressure environment within solid tumors.
Combining two strategies designed to improve the results of cancer treatment – antiangiogenesis drugs and nanomedicines – may only be successful if the smallest nanomedicines are used.
JERSEY CITY, N.J., Feb. 25 /PRNewswire/ -- Psychiatric Congress 2009 announces Rakesh Jain, MD, MPH, one of the nation's leading experts in the field of mental health, as program chair. Dr. Jain is director of psychiatric drug research at the R/D Clinical Research Center in Lake Jackson, Texas.
- The deadly nightshade, Atropa Belladonna, which possesses stupefying or poisonous properties.
- A sleeping-potion; a soporific.
- To mutter deliriously.